FR2658204A1 - Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv. - Google Patents

Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv. Download PDF

Info

Publication number
FR2658204A1
FR2658204A1 FR9001596A FR9001596A FR2658204A1 FR 2658204 A1 FR2658204 A1 FR 2658204A1 FR 9001596 A FR9001596 A FR 9001596A FR 9001596 A FR9001596 A FR 9001596A FR 2658204 A1 FR2658204 A1 FR 2658204A1
Authority
FR
France
Prior art keywords
cyclin
sequence
detection
diagnosis
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9001596A
Other languages
English (en)
French (fr)
Other versions
FR2658204B1 (https=
Inventor
Brechot Christian
Wang Jian
Chenivesse Xavier
Henglein Berthold
Zindy Frederique
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut National de la Sante et de la Recherche Medicale INSERM
Original Assignee
Institut National de la Sante et de la Recherche Medicale INSERM
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9001596A priority Critical patent/FR2658204A1/fr
Application filed by Institut National de la Sante et de la Recherche Medicale INSERM filed Critical Institut National de la Sante et de la Recherche Medicale INSERM
Priority to PCT/FR1991/000089 priority patent/WO1991012324A1/fr
Priority to EP91904077A priority patent/EP0471804B1/fr
Priority to ES91904077T priority patent/ES2181667T3/es
Priority to AT91904077T priority patent/ATE220717T1/de
Priority to DE69133067T priority patent/DE69133067T2/de
Publication of FR2658204A1 publication Critical patent/FR2658204A1/fr
Application granted granted Critical
Publication of FR2658204B1 publication Critical patent/FR2658204B1/fr
Priority to US08/460,895 priority patent/US5849508A/en
Priority to US09/210,889 priority patent/US6103887A/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4738—Cell cycle regulated proteins, e.g. cyclin, CDC, INK-CCR
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3513—Protein; Peptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR9001596A 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv. Granted FR2658204A1 (fr)

Priority Applications (8)

Application Number Priority Date Filing Date Title
FR9001596A FR2658204A1 (fr) 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
EP91904077A EP0471804B1 (fr) 1990-02-12 1991-02-06 Nouvelles compositions de cycline a humaine et leur procede de production, sequence nucleotidique correspondante, procede et agents de detection ou de diagnostic de la proliferation cellulaire et procede et agents d'inhibition de la proliferation cellulaire
ES91904077T ES2181667T3 (es) 1990-02-12 1991-02-06 Composiciones nuevas de ciclina a humana y su procedimiento de produccion, secuencia nucleotidica correspondiente, procedimiento y agentes para la deteccion o diagnostico de la proliferacion celular y procedimiento y agentes para la inhibicion de la proliferacion celular.
AT91904077T ATE220717T1 (de) 1990-02-12 1991-02-06 Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung
PCT/FR1991/000089 WO1991012324A1 (fr) 1990-02-12 1991-02-06 Nouvelles compositions de cycline a humaine et leur procede de production, sequence nucleotidique correspondante, procede et agents de detection ou de diagnostic de la proliferation cellulaire et procede et agents d'inhibition de la proliferation cellulaire
DE69133067T DE69133067T2 (de) 1990-02-12 1991-02-06 Menschliche cyclin-a-zusammensetzungen, verfahren zu ihrer herstellung, nukleotidsequenz, verfahren und wirkstoffe zur bestimmung oder diagnose von zellvermehrung, verfahren und wirkstoffe zur hemmung der zellvermehrung
US08/460,895 US5849508A (en) 1990-02-12 1995-06-05 Process for the detection of cell proliferation by detecting human cyclin A
US09/210,889 US6103887A (en) 1990-02-12 1998-12-15 Nucleotide sequence encoding human cyclin A

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9001596A FR2658204A1 (fr) 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.

Publications (2)

Publication Number Publication Date
FR2658204A1 true FR2658204A1 (fr) 1991-08-16
FR2658204B1 FR2658204B1 (https=) 1994-08-19

Family

ID=9393594

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9001596A Granted FR2658204A1 (fr) 1990-02-12 1990-02-12 Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.

Country Status (7)

Country Link
US (2) US5849508A (https=)
EP (1) EP0471804B1 (https=)
AT (1) ATE220717T1 (https=)
DE (1) DE69133067T2 (https=)
ES (1) ES2181667T3 (https=)
FR (1) FR2658204A1 (https=)
WO (1) WO1991012324A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE273386T1 (de) * 1991-09-20 2004-08-15 Hutchinson Fred Cancer Res Menschliches cyclin e
FR2712301A1 (fr) * 1993-11-10 1995-05-19 Inst Nat Sante Rech Med Séquence nucléotidique du promoteur de la cycline A humaine et séquences anti-sens y relatives.
GB0123856D0 (en) * 2001-10-05 2001-11-28 Amersham Pharm Biotech Uk Ltd Method for determining cell cycle position
WO2004040314A1 (en) * 2002-10-31 2004-05-13 Chemometec A/S A method for assessment of particles
WO2006119435A2 (en) * 2005-05-04 2006-11-09 Invitrogen Corporation Identification of cancer biomarkers and phosphorylated proteins

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321362A1 (en) * 1987-12-16 1989-06-21 Institut Pasteur Retinoic acid receptor and derivatives thereof, DNA endocing either substance and use of the proteins and of the DNA

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4544545A (en) * 1983-06-20 1985-10-01 Trustees University Of Massachusetts Liposomes containing modified cholesterol for organ targeting

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0321362A1 (en) * 1987-12-16 1989-06-21 Institut Pasteur Retinoic acid receptor and derivatives thereof, DNA endocing either substance and use of the proteins and of the DNA

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
CELL *
EXPERIMENTAL RESEARCH *
HUMAN GENETICS *
JOURNAL OF VIROLOGY *
NATURE *

Also Published As

Publication number Publication date
EP0471804B1 (fr) 2002-07-17
ES2181667T3 (es) 2003-03-01
US6103887A (en) 2000-08-15
FR2658204B1 (https=) 1994-08-19
ATE220717T1 (de) 2002-08-15
DE69133067D1 (de) 2002-08-22
WO1991012324A1 (fr) 1991-08-22
DE69133067T2 (de) 2003-05-08
US5849508A (en) 1998-12-15
EP0471804A1 (fr) 1992-02-26

Similar Documents

Publication Publication Date Title
Wang et al. Hepatitis B virus integration in a cyclin A gene in a hepatocellular carcinoma
Jenny et al. Characterization of cleavage and polyadenylation specificity factor and cloning of its 100-kilodalton subunit
JP5490343B2 (ja) Ｊｎｋシグナル導入経路の細胞透過性ペプチドインヒビター
CA2576293C (en) Agents capable of downregulating an msf-a-dependent hif-1alpha and use thereof in cancer treatment
JPH06501938A (ja) ペプチドよりなるｈｉｖ複製阻害剤
JPH08500828A (ja) ファルネシルトランスフェラーゼの同定、特性評価および阻害方法、ならびにその組成
Lahiri et al. A cDNA clone of the hnRNP C proteins and its homology with the single-stranded DNA binding protein UP2
WO1994003597A1 (fr) Peptides inhibant l'activite des proteines ras, preparation et utilisation
FR2658204A1 (fr) Nouvelles compositions de cycline a humaine, sequence nucleotidique correspondante, et agents de detection ou de diagnostic de mutations hepatocellulaires induites par le virus hbv.
Ou et al. Cloning and charaterization of a human ribosomal protein gene with enhanced expression in fetal and neoplastic cells
FR2691475A1 (fr) Séquence d'ADN des produits de fusion résultant de la translocation chromosomique récurrente t(11;22) (q24;q12) associée au développement d'un groupe de tumeurs cancéreuses.
EP0877758B1 (fr) PROTEINE PURIFIEE SR-p70
EP0750508A1 (fr) RETROPEPTIDES, ANTICORPS DIRIGES CONTRE CES DERNIERS, ET LEURS UTILISATIONS POUR LA VACCINATION ET LE DIAGNOSTIC $i(IN VITRO)
EP0206849B1 (fr) Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif
KR100381080B1 (ko) 양이온성아미노산수송기단백질을암호화하는유전자
WO1986006494A1 (fr) Moyens pour le diagnostic in vitro de cellules malignesorigi naires du tube digestif
CN1138295A (zh) 新的肿瘤阻抑基因
WO1990000179A2 (fr) Nouvelles proteins, adn les codant et leur usage
JP2002503466A (ja) 網膜芽細胞腫タンパク質複合体および網膜芽細胞腫相互作用タンパク質
Du Bois et al. Purification and characterization of recombinant forms of TCL-1 and MTCP-1 proteins
CA1280079C (fr) Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif
Chodchoy Regulation of mouse histone gene expression
FR2618439A1 (fr) Sequences d'amino-acides reproduisant au moins en partie la sequence des lectines animales et humaines, leurs procedes d'obtention, leurs applications diagnostiques et therapeutiques
JPWO2002064770A1 (ja) 新規スカベンジャー受容体クラスａ蛋白質
FR2720748A1 (fr) Protéines du complexe BTF2 et leurs applications.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20051031